|
C12ORF51 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.124200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.402400E-02 |
| Normal-vs-Stage2 |
2.599200E-01 |
| Normal-vs-Stage3 |
7.993900E-02 |
| Normal-vs-Stage4 |
2.300900E-03 |
| Stage1-vs-Stage2 |
8.696800E-01 |
| Stage1-vs-Stage3 |
7.116600E-01 |
| Stage1-vs-Stage4 |
1.443580E-01 |
| Stage2-vs-Stage3 |
7.009000E-01 |
| Stage2-vs-Stage4 |
1.782240E-01 |
| Stage3-vs-Stage4 |
2.874600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.442300E-02 |
| Normal-vs-AfricanAmerican |
5.056000E-02 |
| Normal-vs-Asian |
2.170300E-02 |
| Caucasian-vs-AfricanAmerican |
6.760400E-01 |
| Caucasian-vs-Asian |
3.580800E-01 |
| AfricanAmerican-vs-Asian |
4.301000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.448200E-02 |
| Normal-vs-Female |
6.051000E-01 |
| Male-vs-Female |
7.849800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.207700E-02 |
| Normal-vs-Extreme_Weight |
1.777260E-03 |
| Normal-vs-Obese |
4.246800E-01 |
| Normal-vs-Extreme_Obese |
2.718200E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.395600E-01 |
| Normal_Weight-vs-Obese |
1.509350E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.599600E-01 |
| Extreme_Weight-vs-Obese |
3.162000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.783800E-01 |
| Obese-vs-Extreme_Obese |
2.577800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.202200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.375600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.702900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.564800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.309800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.303400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.618300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.426100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.298100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.110000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.643000E-01 |
| Normal-VS-Type2 PRCC |
4.21449999999934E-05 |
| Normal-VS-KIRP CIMP |
5.226000E-01 |
| Normal-VS-Unclassified PRCC |
7.933400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.186000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.915000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.725800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.706230E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.016600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.810000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.678550E-03 |
| Normal-vs-N1 |
2.063800E-01 |
| Normal-vs-N2 |
2.835000E-01 |
| N0-vs-N1 |
2.999400E-01 |
| N0-vs-N2 |
7.152200E-01 |
| N1-vs-N2 |
8.900400E-01 |
|
|
